Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | BMY | AMGN | GSK | GILD |
| Company | Adaptimmune Ther ADR | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.1300 | 44.75 | 312.89 | 44.98 | 64.72 |
| High | 1.2100 | 44.97 | 314.89 | 45.10 | 66.20 |
| Low | 1.0800 | 44.30 | 309.82 | 44.80 | 64.67 |
| Last | 1.1200 | 44.94 | 310.15 | 45.07 | 65.96 |
| Change | -0.0200 | +0.20 | -2.71 | +0.40 | +1.38 |
| % Change | -1.75% | +0.45% | -0.87% | +0.90% | +2.14% |
| Volume | 529,100 | 8,697,000 | 2,611,700 | 3,770,600 | 8,732,800 |
| 20-Day Average Volume | 1,080,045 | 14,168,250 | 2,930,855 | 3,315,255 | 7,614,355 |
| Previous Close | 1.1400 | 44.74 | 312.86 | 44.67 | 64.58 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0944 | 46.01 | 281.61 | 41.89 | 65.99 |
| 20-Day Raw Stochastic | 65.60% | 25.81% | 79.89% | 99.50% | 39.52% |
| 20-Day Relative Strength | 45.62% | 36.90% | 65.95% | 71.23% | 39.82% |
| Weighted Alpha | -42.10 | -34.29 | +34.03 | +30.07 | -19.29 |
| Today's Opinion | 24% Buy | 100% Sell | 56% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 40% Buy | 100% Sell | 56% Buy | 88% Buy | 100% Sell |
| Last Month's Opinion | 56% Buy | 56% Sell | 40% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.88% since 05/03/24 | +2.16% since 05/03/24 | -0.37% since 05/03/24 | +3.61% since 05/03/24 | +1.82% since 05/03/24 |
| Low | 1.0200 on 05/08/24 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 43.17 on 05/06/24 | 64.34 on 05/06/24 |
| High | 1.2300 on 05/06/24 | 44.97 on 05/10/24 | 314.89 on 05/10/24 | 45.10 on 05/10/24 | 66.20 on 05/10/24 |
| 1-Month | |||||
| %Chg | -11.81% since 04/10/24 | -10.64% since 04/10/24 | +16.40% since 04/10/24 | +10.76% since 04/10/24 | -3.17% since 04/10/24 |
| Low | 0.8721 on 04/18/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 64.33 on 05/03/24 |
| High | 1.3400 on 04/11/24 | 50.58 on 04/11/24 | 322.60 on 05/03/24 | 45.10 on 05/10/24 | 69.03 on 04/11/24 |
| 3-Month | |||||
| %Chg | -10.40% since 02/09/24 | -9.78% since 02/09/24 | +6.54% since 02/09/24 | +7.54% since 02/09/24 | -10.47% since 02/09/24 |
| Low | 0.8721 on 04/18/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 64.33 on 05/03/24 |
| High | 2.0500 on 03/08/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 45.10 on 05/10/24 | 76.21 on 03/11/24 |
| 6-Month | |||||
| %Chg | +138.25% since 11/10/23 | -11.20% since 11/10/23 | +16.03% since 11/10/23 | +30.98% since 11/10/23 | -13.12% since 11/10/23 |
| Low | 0.4200 on 11/28/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 34.29 on 11/16/23 | 64.33 on 05/03/24 |
| High | 2.0500 on 03/08/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 45.10 on 05/10/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 281,381 | 90,692,464 | 167,829,040 | 92,575,888 | 80,407,072 |
| Shares Outstanding, K | 246,825 | 2,027,100 | 536,435 | 2,072,440 | 1,245,077 |
| Annual Sales | 60,280,000 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | -113,870,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | 230,000 | 11,865,000,000 | 7,447,000,000 | 9,337,020,000 | 6,686,000,000 |
| Last Quarter Net Income | -47,920,000 | -11,911,000,000 | -113,000,000 | 1,326,430,000 | -4,170,000,000 |
| 60-Month Beta | 2.44 | 0.45 | 0.60 | 0.65 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 03/06/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | 1.09 on 05/01/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/15/24 | 04/25/24 | 05/02/24 | 05/01/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.397 on 02/22/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 05/16/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.59 | 16.50 | 10.93 | 16.11 |